clinical trial · NCT07112144
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Changchun BCHT Biotechnology Co.·phase3·recruiting·n = 1,650
Prevent Whooping CoughPrevent DiphtheriaPrevent TetanusDTacPDTaPDTacP-IPV/Hib
brief summary
The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.
started
Jun 13, 2025
primary completion
Jun 1, 2032
completion
Jun 1, 2032
last updated
Aug 8, 2025
official title
Phase III Clinical Trials to Evaluate the Immunogenicity and Safety of Adsorption-free Diphtheria and Tetanus (Three-component) Combined Vaccine in 2-month-old Infants and Young Children
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol